TH
HZNP

Timber Hill’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Timber Hill’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-12,667
Closed -$42K – 3331
2013
Q3 		$42K Sell
12,667
-1,406
-10% -$3.71K ﹤0.01% 3147
2013
Q2 		$35K Buy
+14,073
New +$33.8K ﹤0.01% 3167

Other funds holding HZNP

MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Timber Hill's HZNP Position: Q4 2013 in Review

Timber Hill sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2013, closing a stake of 12,667 shares — an estimated $42K sold.

Timber Hill first reported a position in HZNP in Q2 2013 and held it in 2 quarters. The position peaked at $42K in Q3 2013. 95 funds tracked by Wall St. Rank hold HZNP as of Q4 2013.

  • Timber Hill reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2013 after selling out during the quarter.
  • Timber Hill sold 12,667 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2013, an estimated $42K.
  • Timber Hill first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 2 quarters.
  • Timber Hill's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $42K in Q3 2013.
  • 95 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2013.

Based on Timber Hill's 13F filing for Q4 2013, filed 14 Feb 2014.